Afrezza Side Effects: Clinical Considerations and Safety Protocols in Diabetes Management
Overview
This paper examines the side effects and clinical considerations for Afrezza, a rapid-acting inhaled insulin used to improve glycemic control in adult diabetic patients. The paper discusses contraindications, monitoring requirements, and severe adverse reactions including anaphylaxis, emphasizing the importance of medical professional supervision and patient education.
What this coursework covers
- Introduction to Afrezza and its approved indications for diabetes mellitus treatment
- Contraindications and usage restrictions including type 1 diabetes considerations and smoking patients
- Glucose monitoring protocols and the responsibility of healthcare providers
- Severe adverse reactions including anaphylaxis and hypersensitivity management
Preview
Afrezza Side Effects
Name
Institution
Course
Professor
Date
Afrezza Side Effects
"AFREZZA® is a rapid-acting inhaled insulin indicated to improve glycemic control in adult patients with diabetes mellitus. " (Afrezza, 2014). Although the drug has been proven effective, it should not be used as a substitute for other medication for patients with type 1 diabetes. The drug is only effective if used in combination with long-acting insulin. It is also critical for patients to understand that they should not use the medicine to treat diabetic ketoacidosis. Finally, medical professionals should not prescribe the drug to patients smoking.
"Glucose monitoring is essential for patients receiving insulin therapy" (Afrezza, 2014). It is the responsibility of medical professionals to ensure they advise their patients on regularly monitoring their sugar levels. The changes in the strength of insulin will impact how glycemic is controlled. By having information about how the sugar levels have been, it will be possible to know if the dosage should be increased or decreased. Pharmacists should also not give out the medication without a prescription.
"Severe, life-threatening, generalized allergy, including anaphylaxis, can occur with insulin products, including AFREZZA" (Afrezza, 2014). Although the drug has proven effective in treating diabetes, it may have severe side effects if not correctly administered. A medical professional must keep a constant watch on a patient using the drug to ensure no severe reactions. In case of a reaction, the medication should be stopped until the side effects have been resolved.